Clinical Trial Enrolls 250+ Participants for Ebola Prevention Drug in Congo

Source Summary

A clinical trial has enrolled more than 250 participants to test a drug designed to prevent Ebola infection in Congo. Experts have identified this trial as a critical effort to combat the deadliest Ebola outbreak recorded in the Central African country.

Why it matters

The trial represents a direct public-health response to Congo's most severe Ebola outbreak, testing a preventive intervention that could reduce transmission and mortality.